These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15045522)

  • 61. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.
    Tozaki M
    Breast Cancer; 2013 Jan; 20(1):13-20. PubMed ID: 22109641
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MR imaging of ductal carcinoma in situ.
    Newstead GM
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):225-40, viii. PubMed ID: 20494308
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
    Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
    AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [In situ ductal carcinoma of the breast: a diagnostic challenge].
    Fuchsjäger MH; Helbich TH
    Wien Med Wochenschr Suppl; 2002; (113):69-73. PubMed ID: 12621847
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
    Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
    Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of second-look ultrasound examinations for MR-detected lesions in patients with breast cancer.
    Lee SH; Kim SM; Jang M; Yun BL; Kang E; Kim SW; Park SY; Ahn HS; Chang JH; Yoo Y; Song TK; Moon WK
    Ultraschall Med; 2015 Apr; 36(2):140-8. PubMed ID: 25750138
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

  • 72. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
    Kaiser WA
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery.
    Boné B; Aspelin P; Isberg B; Perbeck L; Veress B
    Acta Radiol; 1995 Mar; 36(2):111-6. PubMed ID: 7710787
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity.
    Heacock L; Melsaether AN; Heller SL; Gao Y; Pysarenko KM; Babb JS; Kim SG; Moy L
    Eur J Radiol; 2016 Apr; 85(4):815-23. PubMed ID: 26971429
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.
    Gribbestad IS; Nilsen G; Fjøsne HE; Kvinnsland S; Haugen OA; Rinck PA
    J Magn Reson Imaging; 1994; 4(3):477-80. PubMed ID: 8061451
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation.
    Ghai S; Muradali D; Bukhanov K; Kulkarni S
    AJR Am J Roentgenol; 2005 Aug; 185(2):481-7. PubMed ID: 16037524
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
    Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
    Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Magnetic resonance galactography for a patient with nipple discharge.
    Yoshimoto M; Kasumi F; Iwase T; Takahashi K; Tada T; Uchida Y
    Breast Cancer Res Treat; 1997 Jan; 42(1):87-90. PubMed ID: 9116323
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical application of multidetector row computed tomography in patient with breast cancer.
    Kang DK; Kim MJ; Jung YS; Yim H
    J Comput Assist Tomogr; 2008; 32(4):583-98. PubMed ID: 18664847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.